Overview

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Assess the impact in outcome of the use of zoledronic acid in multiple myeloma.
Details
Lead Sponsor:
Instituto Mexicano del Seguro Social
Treatments:
Diphosphonates
Zoledronic Acid